blaGES carrying Pseudomonas aeruginosa isolates from a public hospital in Rio de Janeiro, Brazil

Brazilian Journal of Infectious Diseases

Volumn 10, Issue 4, 2006, Pages 251-253

  Pellegrino, Flávia L P C ^a   Netto dos Santos, Kátia R ^a   Riley, Lee W ^b   Moreira, Beatriz Meurer ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antibiotics; blaGES; Brazil; Pseudomonas aeruginosa; Public hospital; Rio de Janeiro

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BRAZIL; CONTROLLED STUDY; DRUG POTENTIATION; GENOTYPE; NONHUMAN; PROTEIN ANALYSIS; PSEUDOMONAS AERUGINOSA; PUBLIC HOSPITAL; BIOSYNTHESIS; DRUG EFFECT; GENETICS; GRAM NEGATIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BRAZIL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; GENOTYPE; HOSPITALS, PUBLIC; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 33947413380     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702006000400007     Document Type: Article

References (15)

1. Livermore D.M. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557-84.
2. Poirel L., Thomas I.L., Naas T., et al. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 2000;44:622-32.
3. Nordmann P., Guibert M. Extended-spectrum beta-lactamases in Pseudomonas aeruginosa. J Antimicrob Chemother 1998;42:128-31.
4. GES-1 and a fused product of aac(3)-Ib/aac(6′)-Ib gene cassettes in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002;46:638-45.
5. Duarte A., Boavida F., Grosso F., et al. Outbreak of GES-1 beta-lactamase-producing multidrug-resistant Klebsiella pneumoniae in a university hospital in Lisbon, Portugal. Antimicrob Agents Chemother 2003;47:1481-2.
6. Castanheira M., Mendes R.E., Walsh T.R. Emergence of the extended-spectrum beta-lactamase GES-1 in a Pseudomonas aeruginosa strain from Brazil: Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 2004;48:2344-45.
7. Poirel L., Weldhagen GF., Naas T., et al. GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob Agents Chemother 2001;45:2598-2603.
8. Giakkoupi P., Tzouvelekis L.S., Tsakris A., et al. IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical isolate. Antimicrob Agents Chemother 2000;44:2247-53.
9. Kartali G, Tzelepi E., Poumaras S., et al. Outbreak of infections caused by Enterobacter cloacae producing the integron-associated beta-lactamase IBC-1 in a neonatal intensive care unit of a Greek Hospital. Antimicrob Agents Chemother 2002;46:1577-80.
10. Mavroidi A., Tzelepi E., Tsakris A., et al. An integron-associated class A beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1. J Antimicrob Chemother 2001;48:627-30.
11. Wachino J., Doi Y., Yamane K., et al. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class A beta-lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob Agents Chemother 2004;48:1960-67.
12. Vourli S., Giakkoupi P., Miriagou V., et al. Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiol Letters 2004;234:209-13
13. Pellegrino F.L.P.C., Teixeira L.M., Carvalho M.G.S., et al. Occurrence of a multidrug-resistant Pseudomonas aeruginosa genotype in different hospitals in Rio de Janeiro, Brazil. J Clin Microbiol 2002;40:2420-24.
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests; Seventh edition. Approved standard M2-A7. NCCLS, Wayne, PA, 2000.
15. Weldhagen G.F., Poirel L., Nordmann P. Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: Novel developments and clinical impact. Antimicrob Agents Chemother 2003;47:2385-92.